Showing results (11-20 of 47) with videos related to
Sort By:
Pageof 5
Communicable Diseases Intelligence Quarterly Report|January 29, 2003
Norwalk-like virus outbreak in Canberra: implications for infection control in aged care facilitiesMegge Miller, Louise Carter, Katrina Scott, et al.BMC Cancer|March 28, 2025
A single centre experience of patients with rare cancers referred for early phase clinical trialsAngelos Angelakas, Natalie Cook, Donna M Graham, et al.British Journal of Cancer|August 8, 2022
Patient attrition in Molecular Tumour Boards: a systematic reviewHannah Frost, Donna M Graham, Louise Carter, et al.Nature Reviews. Clinical Oncology|January 22, 2014
Molecular analysis of circulating tumour cells-biology and biomarkersMatthew G Krebs, Robert L Metcalf, Louise Carter, et al.British Journal of Cancer|January 10, 2026
Expansion cohorts in phase 1 oncology trials: a systematic review of their design, implementation and outcomesJulio Herrero Colomina, Xinjie Hu, Habana Dinizulu, et al.BMC Cancer|April 19, 2024
Development and validation of a patient reported experience measure for experimental cancer medicines (PREM-ECM) and their carers (PREM-ECM-Carer)Chelsea S Sawyer, Sally Taylor, Louise Carter, et al.Psycho-Oncology|April 6, 2026
Psychological Screening and Support for Patients Enrolled in Early-Phase Cancer Clinical Trials and the Possible Barriers: A Real-World Tertiary Center Implementation StudyMatthew D Robinson, Ruiyang Yan, Amy Smith, et al.BMJ Open|October 6, 2021
Oncology patients' experiences in experimental medicine cancer trials: a qualitative studyChelsea Sawyer, Laurie Preston, Sally Taylor, et al.NPJ Precision Oncology|March 26, 2025
Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patientsJulio Herrero Colomina, Eleanor Johnston, Kate Duffus, et al.Journal of Gastroenterology and Hepatology|January 30, 2004
Surveillance for newly acquired hepatitis C in AustraliaMonica C Robotin, Joy Copland, Graham Tallis, et al.Pageof 5